SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Posted by Faye Duncan on Nov 8th, 2024

SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.04), Zacks reports. SOPHiA GENETICS had a negative net margin of 110.71% and a negative return on equity of 55.06%. The firm had revenue of $15.85 million for the quarter, compared to analyst estimates of $15.90 million. During the same period last year, the company earned ($0.21) EPS. SOPHiA GENETICS updated its FY 2024 guidance to EPS.

SOPHiA GENETICS Stock Performance

NASDAQ:SOPH opened at $3.40 on Friday. SOPHiA GENETICS has a twelve month low of $2.70 and a twelve month high of $7.37. The stock’s 50 day moving average price is $3.66 and its two-hundred day moving average price is $4.23. The company has a quick ratio of 4.17, a current ratio of 3.80 and a debt-to-equity ratio of 0.12.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on SOPH. Morgan Stanley lowered SOPHiA GENETICS from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $10.00 to $5.00 in a research note on Wednesday, August 7th. Royal Bank of Canada dropped their target price on SOPHiA GENETICS from $8.00 to $7.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th.

Get Our Latest Stock Report on SOPH

SOPHiA GENETICS Company Profile

(Get Free Report)

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.